Pancreas Cancer News and Archives
	Phase III Randomised Comparison of Gemcitabine (GEM) Versus Gemcitabine Plus Capecitabine (GEM-CAP) in Patients with Advanced Pancreatic Cancer November 12, 2005 Chua YJ, Cunningham D, et al. European Cancer Conference (ECCO 13), presentation/abstract PS11, Paris, France, 2005 November 2. Royal Marsden Hospital, London, England. New research has found that adding another chemotherapy drug to standard treatment slightly prolongs the lives of patients with inoperable pancreatic cancer, raising the possibility that the combination might cure a greater proportion of people whose tumors are cut out. ...full article
	For educational purposes only; not to be relied upon Please read Pancreatica Disclaimer
	Home | In The News | Links | Newswire | Donations FAQ | Clinical Trials Database | Research Resources | About Us
	webmaster
	©2000-2008 Pancreatica.org - All Rights Reserved www.pancreatica.org